FSCN1 and adenocarcinoma: Recently, Del Rosario et al (2001) have reported in abstract form only that fascin immunoreactivity was detectable in 31% of 55 adenocarcinomas and 89% of 55 squamous cell carcinomas, correlating significantly with high tumour grade in the former and low tumour grade in the latter.